ImmunityBio, Inc. (IBRX)

Typically moves ±6.77% on earnings
EARNINGS ANALYTICS
event_note Approx. Next Earnings: ~2026-11-06 APPROXIMATE
search

Across 13 earnings reports since Jun 11, 2021, ImmunityBio, Inc. (IBRX) has a clear post-earnings pattern. It moves ±6.77% on average after reporting and finishes higher 38.5% of the time. Its largest post-earnings gain was +14.01% (May 12, 2025) and its largest decline was -13.37% (Mar 03, 2025). The next earnings report is predicted for 2026-11-06 (approximate).

Earnings reactions

How IBRX moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

13

Avg Abs. Movement

±6.77%

Positive %

38.5%

Negative %

61.5%

Historical Earnings Statistics

Date Timing Earnings move SEC Filing
Aug 04, 2026 ☀ PRE -2.8% open_in_new
May 07, 2026 ☀ PRE -7.63% open_in_new
Apr 09, 2026 ☀ PRE +7.16% open_in_new
Feb 23, 2026 ☀ PRE +12.99% open_in_new
event

Earnings Count

13

Total earnings in dataset

trending_up

Avg Abs. Movement

±6.77%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 32 →
32
Funds holding
$713668610
Total value held
Buying
22 added · 7 reduced
Blackrock, Inc.
$298398958 +29.37%
State Street Corp
$187343325 +20.84%
Northern Trust Corp
$31213746 +42.34%
Morgan Stanley
$30053096 -14.59%
Goldman Sachs Group Inc
$28316099 -0.09%

SEC Filing Types

description 4
215 chevron_right
description 8-K
98 chevron_right
description 10-Q
34 chevron_right
description 3
23 chevron_right
description 424B5
14 chevron_right
description CORRESP
13 chevron_right
description 10-K
11 chevron_right
description 425
11 chevron_right

Recent SEC Filings

10 most recent
Form Date Filed View on EDGAR
SCHEDULE 13D/A 20260806 open_in_new SEC.gov
10-Q 20260804 open_in_new SEC.gov
8-K 20260804 open_in_new SEC.gov
8-K 20260730 open_in_new SEC.gov
4 20260706 open_in_new SEC.gov
4 20260706 open_in_new SEC.gov
144 20260702 open_in_new SEC.gov
144 20260701 open_in_new SEC.gov
4 20260701 open_in_new SEC.gov
144 20260630 open_in_new SEC.gov

Frequently asked about IBRX earnings

When does ImmunityBio, Inc. report earnings next? expand_more

ImmunityBio, Inc. (IBRX)'s next earnings date is approximate for 2026-11-06. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does IBRX stock move after earnings? expand_more

Over 13 reports, IBRX has moved an average of ±6.77% the session after earnings, closing higher 38.5% of the time.

What was IBRX's biggest post-earnings move? expand_more

IBRX's largest post-earnings gain on record was +14.01% on May 12, 2025, and its largest decline was -13.37% on Mar 03, 2025.

Where can I find ImmunityBio, Inc.'s SEC filings? expand_more

All of ImmunityBio, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.

Sector peers